Isotopia Molecular Imaging was founded in 2007 by distinguished Israeli scientists and experts specializing in radiopharmaceuticals, in collaboration with the International Metronotario investment organization. The company's standout product is the radioisotope Lutetium-177 (both C.A and N.C.A), which has garnered significant attention and demonstrated considerable potential in the treatment of various advanced-stage cancers. ...
Isotopia Molecular Imaging was founded in 2007 by distinguished Israeli scientists and experts specializing in radiopharmaceuticals, in collaboration with the International Metronotario investment organization. The company's standout product is the radioisotope Lutetium-177 (both C.A and N.C.A), which has garnered significant attention and demonstrated considerable potential in the treatment of various advanced-stage cancers. Notably, it has shown promise in addressing conditions such as metastatic prostate cancer and neuroendocrine tumors.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.